Heart device study pulled before it even started
NCT ID NCT04684212
First seen Nov 05, 2025 · Last updated May 10, 2026 · Updated 24 times
Summary
This study aimed to see if a device called LAmbre Plus could safely close off a small pouch in the heart (the left atrial appendage) in people with an irregular heartbeat (atrial fibrillation) who have a high risk of stroke. The goal was to reduce stroke risk without needing long-term blood thinners. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
Conditions
Explore the condition pages connected to this study.